Compounds
US9428452B2 · kind B2 · utility
7Cited by
1References
39Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 25, 2013 |
| Grant date | Aug 30, 2016 |
| Priority date | — |
| Expiry date | Apr 25, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2601/02
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention is directed to novel retinoid-related orphan receptor gamma (RORγ) modulators, processes for their preparation, pharmaceutical compositions containing these modulators, and their use in the treatment of inflammatory, metabolic and autoimmune diseases mediated by RORγ.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.